Literature DB >> 26764479

The Gut Microbiome, Its Metabolome, and Their Relationship to Health and Disease.

Gary D Wu.   

Abstract

Despite its importance in maintaining the health of the host, growing evidence suggests that gut microbiota may also be an important factor in the pathogenesis of various diseases. The composition of the microbiota can be influenced by many factors, including age, genetics, host environment, and diet. There are epidemiologic data associating diet with the development of inflammatory bowel disease as well as evidence that diet can influence both the form and the function of the microbiome. Based on this evidence, studies are now underway to examine the effect of defined formula diets, an effective therapeutic modality in Crohn's disease, on both the gut microbiome and its metabolome as a therapeutic probe. Diet has an impact upon both the composition and the function of the microbiota in part through small-molecule production that may influence the development of both immune-mediated and metabolic diseases. By comparing dietary intake, the gut microbiota, and the plasma metabolome in omnivores versus vegans, we provide evidence that the production of certain bacterial metabolites is constrained by the composition of the gut microbiota. In total, these results demonstrate the potential promise of dietary manipulation of the gut microbiota and its metabolome as a modality to both maintain health and treat disease.
© 2016 Nestec Ltd., Vevey/S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26764479     DOI: 10.1159/000436993

Source DB:  PubMed          Journal:  Nestle Nutr Inst Workshop Ser        ISSN: 1664-2147


  8 in total

1.  Introduction to the special focus issue on the impact of diet on gut microbiota composition and function and future opportunities for nutritional modulation of the gut microbiome to improve human health.

Authors:  Sharon M Donovan
Journal:  Gut Microbes       Date:  2017-02-28

Review 2.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

3.  The gut microbiome in sickle cell disease: Characterization and potential implications.

Authors:  Hassan Brim; James Taylor; Muneer Abbas; Kimberly Vilmenay; Mohammad Daremipouran; Sudhir Varma; Edward Lee; Betty Pace; Waogwende L Song-Naba; Kalpna Gupta; Sergei Nekhai; Patricia O'Neil; Hassan Ashktorab
Journal:  PLoS One       Date:  2021-08-25       Impact factor: 3.240

4.  Ambient Ultrafine Particle Ingestion Alters Gut Microbiota in Association with Increased Atherogenic Lipid Metabolites.

Authors:  Rongsong Li; Jieping Yang; Arian Saffari; Jonathan Jacobs; Kyung In Baek; Greg Hough; Muriel H Larauche; Jianguo Ma; Nelson Jen; Nabila Moussaoui; Bill Zhou; Hanul Kang; Srinivasa Reddy; Susanne M Henning; Matthew J Campen; Joseph Pisegna; Zhaoping Li; Alan M Fogelman; Constantinos Sioutas; Mohamad Navab; Tzung K Hsiai
Journal:  Sci Rep       Date:  2017-02-17       Impact factor: 4.379

5.  The effect of high dietary fiber intake on gestational weight gain, fat accrual, and postpartum weight retention: a randomized clinical trial.

Authors:  Holly R Hull; Amy Herman; Heather Gibbs; Byron Gajewski; Kelli Krase; Susan E Carlson; Debra K Sullivan; Jeannine Goetz
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-24       Impact factor: 3.007

6.  An Embryonic Zebrafish Model to Screen Disruption of Gut-Vascular Barrier upon Exposure to Ambient Ultrafine Particles.

Authors:  Kyung In Baek; Yi Qian; Chih-Chiang Chang; Ryan O'Donnell; Ehsan Soleimanian; Constantinos Sioutas; Rongsong Li; Tzung K Hsiai
Journal:  Toxics       Date:  2020-11-19

Review 7.  Diet, Microbiota and Gut-Lung Connection.

Authors:  Swadha Anand; Sharmila S Mande
Journal:  Front Microbiol       Date:  2018-09-19       Impact factor: 5.640

8.  Therapeutic reduction of lysophospholipids in the digestive tract recapitulates the metabolic benefits of bariatric surgery and promotes diabetes remission.

Authors:  James G Cash; Eddy Konaniah; Narasimha Hegde; David G Kuhel; Miki Watanabe; Lindsey Romick-Rosendale; David Y Hui
Journal:  Mol Metab       Date:  2018-07-26       Impact factor: 7.422

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.